With a rise in precision medicines, high value shipments and emerging shipping routes, global biopharma industry spending on temperature-controlled products is expected to reach $15.7 billion in 2019. To ensure that companies are able to navigate this new product landscape and complex routes in a cost efficient and effective way, they must rely on specialised and trusted partners.
In this report, Pharma IQ explores the current development trends, and how this will affect temperature control and logistics spending in the next 12 to 24 months.
Key benefits of downloading the full report:
Download the full report now >>
Supply chains in a range of industries, including pharma, are becoming digitised. New research forecasts that the value of the Connected Logistics Market is set to reach US$ 41.00 Billion By 2022. This article will take you through six key elements of data management, explaining how in each area inefficiencies in the supply chain can be removed through the advanced data usage and technology.
The key steps that need to be taken to build a successful temperature controlled supply chain in emerging pharmaceutical regions are in some cases vastly different to those faced in developed markets. This eBook will take you through the considerations that should be made when planning your supply chain, with a particular focus on Russia. The areas we have chosen to focus on are connectivity, regulations, demand planning, cost efficiency and flexibility.